DataSheet_7_RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma.xlsx
There is no cost-effective, accurate, and non-invasive method for the detection of esophageal squamous cell carcinoma (ESCC) in clinical practice. We aimed to investigate the diagnostic potential of tumor-educated platelets in ESCC. In this study, seventy-one ESCC patients and eighty healthy individuals were enrolled and divided into a training cohort (23 patients and 27 healthy individuals) and a validation cohort (48 patients and 53 healthy individuals). Next-generation RNA sequencing was performed on platelets isolated from peripheral blood of all participants, and a support vector machine/leave-one-out cross validation (SVM/LOOCV) approach was used for binary classification. A diagnostic signature composed of ARID1A, GTF2H2, and PRKRIR discriminated ESCC patients from healthy individuals with 91.3% sensitivity and 85.2% specificity in the training cohort and 87.5% sensitivity and 81.1% specificity in the validation cohort. The AUC was 0.924 (95% CI, 0.845–0.956) and 0.893 (95% CI, 0.821–0.966), respectively, in the training cohort and validation cohort. This 3-gene platelet RNA signature could effectively discriminate ESCC from healthy control. Our data highlighted the potential of tumor-educated platelets for the noninvasive diagnosis of ESCC. Moreover, we found that keratin and collagen protein families and ECM-related pathways might be involved in tumor progression and metastasis of ESCC, which might provide insights to understand ESCC pathobiology and advance novel therapeutics.
History
References
- https://doi.org//10.3322/caac.21492
- https://doi.org//10.3748/wjg.v21.i26.7933
- https://doi.org//10.1016/S0140-6736(12)60643-6
- https://doi.org//10.3322/caac.21338
- https://doi.org//10.1016/j.tips.2019.01.006
- https://doi.org//10.1182/blood-2018-12-852830
- https://doi.org//10.1016/j.ccell.2015.09.018
- https://doi.org//10.1182/blood-2011-03-344408
- https://doi.org//10.1016/j.biocel.2017.07.018
- https://doi.org//10.1007/s10555-017-9681-1
- https://doi.org//10.1158/0008-5472.CAN-18-0887
- https://doi.org//10.1245/s10434-010-0985-4
- https://doi.org//10.1016/j.ccell.2017.07.004
- https://doi.org//10.1038/nbt.2931
- https://doi.org//10.1093/bioinformatics/btt383
- https://doi.org//10.1073/pnas.211566398
- https://doi.org//10.1016/j.cell.2005.06.015
- https://doi.org//10.1016/j.ccell.2018.03.002
- https://doi.org//10.1182/blood-2016-01-636399
- https://doi.org//10.1186/s13045-018-0669-2
- https://doi.org//10.1016/j.gie.2018.04.2352
- https://doi.org//10.3748/wjg.v26.i15.1708
- https://doi.org//10.1016/j.pharmthera.2018.05.001
- https://doi.org//10.1158/0008-5472.CAN-15-0338
- https://doi.org//10.1186/1476-4598-4-18
- https://doi.org//10.1038/ejhg.2016.203
- https://doi.org//10.1007/s00432-020-03502-5
- https://doi.org//10.1038/ncb3015
- https://doi.org//10.1002/jcb.26651
- https://doi.org//10.1038/s41598-019-43924-x
- https://doi.org//10.3892/ol.2019.9952
- https://doi.org//10.1016/j.omto.2019.12.002
- https://doi.org//10.1017/cts.2017.37
- https://doi.org//10.1158/2159-8290.CD-15-0507
- https://doi.org//10.1016/j.athoracsur.2018.07.077
- https://doi.org//10.3390/biom7030053
- https://doi.org//10.1016/j.lungcan.2017.06.006
- https://doi.org//10.1080/15384101.2017.1339849
- https://doi.org//10.1007/s11033-010-0586-0
- https://doi.org//10.1186/1471-2199-9-103
- https://doi.org//10.1186/1471-2407-6-200
- https://doi.org//10.1186/1471-2407-9-49
- https://doi.org//10.1006/abio.2001.5171
- https://doi.org//10.1002/pmic.200400941
- https://doi.org//10.1186/1471-2199-11-12
- https://doi.org//10.1038/onc.2010.456
- https://doi.org//10.1186/s12967-019-2058-1
- https://doi.org//10.1016/j.bbcan.2018.09.002
- https://doi.org//10.3390/ijms19103028